This BSMO webinar in collaboration with BELNUC, BeSTRO & BGDO offers a comprehensive overview of Radioligand Therapy in Belgium.
Leading experts share clinical insights on PRRT in NETs, the implementation of RLT in prostate cancer, and the patient care pathway. Featuring presentations and a panel discussion, this session is a must-watch for oncology professionals.
🎓 Accreditation requested (INAMI/RIZIV – AFCN/FANC)
Chairs:
Willem Lybaert (BSMO) and Liv Veldeman (BeSTRO)
Expert panel:
Christophe Deroose, UZ Leuven
Karen Geboes, UZ Gent
Anne-Leen Deleu, Institut Jules Bordet
Nadia Withofs, CHU de Liège
19:00 - 19:05 - Welcome and introduction - Willem Lybaert, BSMO, VITAZ - UZA
19:05 - 19:20 - Landscape of RLT in Belgium - Christophe Deroose, UZ Leuven
19:20 - 19:35 - Success story of PRRT in neuroendocrine tumours - Karen
Geboes, UZ Gent
19:35 - 19:50 - How to implement RLT for prostate cancer in Belgium?
- Anne-Leen Deleu, Institut Jules Bordet
19:50 - 20:05 - Building the RLT pathway: infrastructure and patient journey from
MOC to follow-up - Nadia Withofs, CHU de Liège
20:05 - 20:35 - Panel discussion led by the chairs
20:35 - 20:40 - Closing remarks - Liv Veldeman, UZ Gent
